Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

This study has been completed.
Sponsor:
Collaborator:
Scientific research fund Bruges
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00221559
First received: September 12, 2005
Last updated: May 7, 2006
Last verified: May 2006
  Purpose

Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group


Condition Intervention
Cystic Fibrosis
Procedure: Blood sampling for determination of serum Zn

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Estimated Enrollment: 0
Study Start Date: September 2004
Detailed Description:

Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of cystic fibrosis

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00221559

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Scientific research fund Bruges
Investigators
Principal Investigator: Stephanie Van Biervliet, MD University Hospital, Ghent
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00221559     History of Changes
Other Study ID Numbers: UZGhent 001
Study First Received: September 12, 2005
Last Updated: May 7, 2006
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Cystic Fibrosis
Fibrosis
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on August 01, 2014